The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof； wherein G is R1, R2 and R3 are as described herein； pharmaceutical compositions thereof； and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
